M&A Deal Summary

Kiora Pharmaceuticals Acquires Jade Therapeutics

On March 7, 2016, Kiora Pharmaceuticals acquired medical products company Jade Therapeutics

Acquisition Highlights
  • This is Kiora Pharmaceuticals’ 1st transaction in the Medical Products sector.
  • This is Kiora Pharmaceuticals’ 1st transaction in the United States.
  • This is Kiora Pharmaceuticals’ 1st transaction in Utah.

M&A Deal Summary
Date 2016-03-07
Target Jade Therapeutics
Sector Medical Products
Buyer(s) Kiora Pharmaceuticals
Deal Type Add-on Acquisition

Target

Jade Therapeutics

Salt Lake City, Utah, United States
Jade Therapeutics, Inc. is a provider of locally administered, polymer-based products designed to treat poorly-served ophthalmic indications.

Search 202,137 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Kiora Pharmaceuticals

Encinitas, California, United States
Category Company
Founded 1998
Sector Life Science
Employees12
Revenue 3M USD (2019)
DESCRIPTION

Kiora Pharmaceuticals is a clinical-stage specialty pharmaceutical company that is focused on developing and commercializing therapeutics and drug delivery systems for treating diseases of the eye. Kiora Pharmaceuticals was founded in 1998 and is based in Encinitas, California.

DEAL STATS #
Overall 1 of 3
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 1 of 3
State (Utah) 1 of 1
Country (United States) 1 of 2
Year (2016) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-12-21 Panoptes Pharma GES.M.B.H

Wien, Austria

Panoptes Pharma GES.M.B.H is a clinical stage biotech company focused on developing a novel proprietary small molecule for the treatment of severe eye diseases with a high unmet medical need. Panoptes Pharma was founded in 2013 and is based in Wien, Austria.

Buy -
Mergr

Product

Company

Legal